Site 142 — Hialeah, Florida

Public research footprint of Site 142, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Type 2 Diabetes Mellitus · Adjunctive Treatment of Major Depressive Disorder · Moderate to Severe Plaque Psoriasis · Post-ischemic Stroke

Recently updated registry entries

NCT06822790 — Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia (Recruiting)
NCT06347133 — Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (Active Not Recruiting)
NCT05438329 — First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Site 142?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.